Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,214
Closed -$1K 7751
2025
Q2
$1K Hold
2,214
﹤0.01% 6622
2025
Q1
$901 Hold
2,214
﹤0.01% 6640
2024
Q4
$1.47K Hold
2,214
﹤0.01% 6682
2024
Q3
$1.88K Hold
2,214
﹤0.01% 6633
2024
Q2
$1.48K Sell
2,214
-120,357
-98% -$99.9K ﹤0.01% 6564
2024
Q1
$159K Buy
122,571
+122,121
+27,138% +$128K ﹤0.01% 5460
2023
Q4
$258 Hold
450
﹤0.01% 7023
2023
Q3
$339 Hold
450
﹤0.01% 6774
2023
Q2
$329 Sell
450
-98,501
-100% -$91.6K ﹤0.01% 6583
2023
Q1
$75K Buy
98,951
+28,403
+40% +$26.4K ﹤0.01% 5551
2022
Q4
$67K Buy
70,548
+2,135
+3% +$3.02K ﹤0.01% 5510
2022
Q3
$149K Buy
68,413
+1,366
+2% +$4.71K ﹤0.01% 5090
2022
Q2
$235K Buy
67,047
+8,844
+15% +$33K ﹤0.01% 4994
2022
Q1
$293K Buy
58,203
+10,851
+23% +$55K ﹤0.01% 4984
2021
Q4
$297K Buy
47,352
+2,043
+5% +$13.9K ﹤0.01% 5138
2021
Q3
$360K Sell
45,309
-1,363
-3% -$11.2K ﹤0.01% 4911
2021
Q2
$350K Buy
46,672
+26,348
+130% +$184K ﹤0.01% 4923
2021
Q1
$123K Sell
20,324
-3,204
-14% -$24.6K ﹤0.01% 5322
2020
Q4
$133K Buy
23,528
+3,996
+20% +$25.4K ﹤0.01% 4932
2020
Q3
$133K Sell
19,532
-17,546
-47% -$156K ﹤0.01% 4575
2020
Q2
$329K Buy
+37,078
New +$107K ﹤0.01% 4044
2018
Q1
Sell
-2,170
Closed -$14K 5653
2017
Q4
$14K Buy
+2,170
New +$15.2K ﹤0.01% 5219
2015
Q1
Sell
-98,527
Closed -$2.43M 4283
2014
Q4
$2.43M Sell
98,527
-108,347
-52% -$2.78M ﹤0.01% 2855
2014
Q3
$5.62M Sell
206,874
-14,760
-7% -$423K ﹤0.01% 2291
2014
Q2
$6.95M Sell
221,634
-5,492
-2% -$229K ﹤0.01% 1925
2014
Q1
$15.3M Buy
227,126
+225,387
+12,961% +$13.9M ﹤0.01% 1490
2013
Q4
$80K Buy
+1,739
New +$76.5K ﹤0.01% 3934

Other funds holding VXRT

JP Morgan Chase's VXRT Position: Q3 2025 in Review

JP Morgan Chase sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 2,214 shares — an estimated $1K sold.

JP Morgan Chase first reported a position in VXRT in Q4 2013 and held it in 27 quarters. The position peaked at $15.3M in Q1 2014. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • JP Morgan Chase reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 2,214 Vaxart shares in Q3 2025, an estimated $1K.
  • JP Morgan Chase first reported a position in Vaxart in Q4 2013 and held it in 27 quarters.
  • JP Morgan Chase's Vaxart position peaked at $15.3M in Q1 2014.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.